30Oct 2023
Cryocompression to Reduce Peripheral Neuropathy in Gynecologic Cancer

Cryocompression to Reduce Peripheral Neuropathy in Gynecologic Cancer

This study aimed to assess the effectiveness of cryocompression therapy in preventing chemotherapy-induced peripheral neuropathy in gynecologic cancer patients undergoing neurotoxic chemotherapy. The randomized trial involved applying cryocompression to one hand and foot while leaving the other side untreated as a control. The primary outcome measures included the Patient Neurotoxicity Questionnaire (PNQ) and the Semmes-Weinstein monofilament test. The results indicated a 46% reduction in sensory neuropathy on the cryocompression-treated side compared to the control side. The study also revealed improved FACT/GOG-NTX scores on the cryocompression side, highlighting the therapy's efficacy in reducing chemotherapy-induced peripheral sensory neuropathy in gynecologic cancer patients.

  • #gynaecology - ivf

Like

Save

Share